论文标题
EBHI:一种新的肠镜活检组织病理学H&E图像分类评估图像数据集
EBHI:A New Enteroscope Biopsy Histopathological H&E Image Dataset for Image Classification Evaluation
论文作者
论文摘要
背景和目的:大肠癌已成为全球第三大癌症,约占癌症患者的10%。早期发现该疾病对于治疗结直肠癌患者很重要。组织病理学检查是筛查结直肠癌的金标准。然而,目前缺乏结直肠癌的组织病理学图像数据集,尤其是肠镜活检,阻碍了计算机辅助诊断技术的准确评估。方法:本文发表了一种新的公开可用的肠镜活检组织病理学H&E图像数据集(EBHI)。为了证明EBHI数据集的有效性,我们使用具有200倍放大倍率的图像,利用了几种机器学习,卷积神经网络和新型的基于变压器的分类器进行实验和评估。结果:实验结果表明,深度学习方法在EBHI数据集上表现良好。传统的机器学习方法的最高准确度为76.02%,深度学习方法的最高准确度为95.37%。结论:据我们所知,EBHI是第一个公开可用的结直肠组织病理学肠镜活检数据集,具有四个宏伟元素和五种类型的肿瘤分化阶段图像,总计5532张图像。我们认为,EBHI可以吸引研究人员探索新的分类算法,以自动诊断结直肠癌,这可以帮助医生和患者在临床环境中。
Background and purpose: Colorectal cancer has become the third most common cancer worldwide, accounting for approximately 10% of cancer patients. Early detection of the disease is important for the treatment of colorectal cancer patients. Histopathological examination is the gold standard for screening colorectal cancer. However, the current lack of histopathological image datasets of colorectal cancer, especially enteroscope biopsies, hinders the accurate evaluation of computer-aided diagnosis techniques. Methods: A new publicly available Enteroscope Biopsy Histopathological H&E Image Dataset (EBHI) is published in this paper. To demonstrate the effectiveness of the EBHI dataset, we have utilized several machine learning, convolutional neural networks and novel transformer-based classifiers for experimentation and evaluation, using an image with a magnification of 200x. Results: Experimental results show that the deep learning method performs well on the EBHI dataset. Traditional machine learning methods achieve maximum accuracy of 76.02% and deep learning method achieves a maximum accuracy of 95.37%. Conclusion: To the best of our knowledge, EBHI is the first publicly available colorectal histopathology enteroscope biopsy dataset with four magnifications and five types of images of tumor differentiation stages, totaling 5532 images. We believe that EBHI could attract researchers to explore new classification algorithms for the automated diagnosis of colorectal cancer, which could help physicians and patients in clinical settings.